Literature DB >> 30710137

Top product forecasts for 2019.

Lisa Urquhart1.   

Abstract

Year:  2019        PMID: 30710137     DOI: 10.1038/d41573-019-00012-z

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study.

Authors:  Simone Parisi; Andrea Becciolini; Maria Chiara Ditto; Davide Rozza; Anna Zanetti; Angela Laganà; Clara Lisa Peroni; Chiara Centanaro Di Vittorio; Rosanna Degiovanni; Cristina Realmuto; Carlo Alberto Scirè; Marta Priora; Eleonora Di Donato; Daniele Santilli; Flavio Mozzani; Gianluca Lucchini; Alarico Ariani; Lucia Gardelli; Francesco Girelli; Eugenio Arrigoni; Ilaria Platè; Elena Bravi; Marino Paroli; Rosalba Caccavale; Carlo Salvarani; Gilda Sandri; Federica Lumetti; Alessandro Volpe; Antonio Marchetta; Enrico Fusaro
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

2.  Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis.

Authors:  Maria Chiara Ditto; Simone Parisi; Marta Priora; Silvia Sanna; Clara Lisa Peroni; Angela Laganà; Antonio D'Avolio; Enrico Fusaro
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.